Importance of hematocrit for a tacrolimus target concentration strategy

por Størset, Elisabet, Holford, Nick, Midtvedt, Karsten, Bremer, Sara, Bergan, Stein, Åsberg, Anders
Publicado 2013

Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites—a study in 839 patients with known CYP2D6 genotype

por Wollmann, Birgit M., Størset, Elisabet, Kringen, Marianne Kristiansen, Molden, Espen, Smith, Robert L.
Publicado 2023

Pro-arrhythmic effect of escitalopram and citalopram at serum concentrations commonly observed in older patients – a study based on a cohort of 19,742 patients

por Faraj, Pari, Størset, Elisabet, Hole, Kristine, Smith, Godfrey, Molden, Espen, Dietrichs, Erik Sveberg
Publicado 2023

Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation

por Åsberg, Anders, Midtvedt, Karsten, van Guilder, Mike, Størset, Elisabet, Bremer, Sara, Bergan, Stein, Jelliffe, Roger, Hartmann, Anders, Neely, Michael N
Publicado 2013

Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling

por Størset, Elisabet, Holford, Nick, Hennig, Stefanie, Bergmann, Troels K, Bergan, Stein, Bremer, Sara, Åsberg, Anders, Midtvedt, Karsten, Staatz, Christine E
Publicado 2014